AV drugs may help curb bacteria’s growing level of resistance to antibiotic treatments A new type of drug could help to combat developing antibiotic resistance, a scholarly study finds. Medications that stop bacterias from harming their hosts, than kill them rather, could prevent bugs from evolving resistance to drug treatments, an assessment of research in the field suggests. Scientists have discovered that anti-virulence medicines – which work in a different way to antibiotics – may help curb bacteria's growing level of resistance to antibiotic treatments infection from antibiotics .
Sales this past year and can be projected to be the world’s No. 1-selling drug this year . This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an editorially independent information service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente.. Abbott issues copies of its biologic drugs The Wall Road Journal: Abbott Is Challenging Biotech Drug Copies If the task succeeds, less-expensive versions of complex biologic drugs couldn’t go on sale in the U.S. For years, and consumers may never have usage of facsimiles of existing remedies such as Abbott’s rheumatoid arthritis therapy Humira, which acquired $3.4 billion in U.S.